Shareholder Files Request to Inspect Shareholder Registry, Escalating Management Dispute at Enzychem Lifesciences
Individual shareholder Nam filed a preliminary injunction against Enzychem Lifesciences to inspect and copy the shareholder registry. This is seen as part of an ongoing management dispute.
The applicant requests access to the shareholder registry as of November 27, 2025, and seeks a daily fine of 20 million KRW if the company fails to comply.
The company stated it will respond in accordance with legal procedures, but the lawsuit signals a potential prolongation of the management dispute, which may negatively impact investor sentiment.
[AI Summary]The request for shareholder registry inspection is a common legal tactic in management disputes, indicating that the conflict is ongoing. While short-term stock volatility is likely, there is no direct damage to fundamentals, warranting a neutral stance.
KOSDAQ Filing Information
Filing of Lawsuit, etc. (Management Dispute Lawsuit) (Injunction for Inspection and Copying of Shareholder Registry)